News

Under the partnership, the college will support the development of new and commercial delivery forms of low dose Naltrexone in the form of oral capsules and tablets and

The company has also upgraded its systems to provide current good manufacturer practices (cGMP)-level quality in its home delivery pharmacy in Sioux Falls, South Dakota to prevent deviations,

Selection of the third cardiovascular target by Servier marks the first milestone for miRagen under the collaboration. Servier chief executive officer Dr. Jean-Philippe Seta said, "Micro-RNA is now

OMS824 is developed to selectively inhibit phosphodiesterase 10 enzyme that is expressed in areas of the brain associated with an array of diseases affecting cognition, such as Huntington’s

The late stage products to be submitted for approval include drugs targeting varying diseases such as hepatitis C, immune diseases and schizophrenia, and vaccines for flu, rabies and

The opening of the new facility, which was independently audited and approved as cGMP compliant, represents the final phase of moving Bellwyck’s clinical services from the Patheon Reading

The first proof-of-concept trial is designed to study effects of the humanized antibody in subjects with renal cell carcinoma (RCC). RCC patients who failed the standard of care

The marketing authorization received for Vesomni is related to the "treatment of moderate to severe storage symptoms (urgency, increased micturition frequency) and voiding symptoms associated with benign prostatic

The FDA had approved Diclegis as the only treatment for nausea and vomiting of pregnancy (NVP) when conservative management fails. Duchesnay USA chief executive officer Gilbert Godin said